2m 2m 2m 2m 2m 2m 2m
LYELL IMMUNPHRM (LYEL)
NASDAQ
$16.10+$0.56 (+3.64%)
Price as of Aug 21, 2026 7:30 PM EDT- $380.6MMarket Cap
- 44.33%1-Year Change
- BiotechnologyIndustry
LYELL IMMUNPHRM (LYEL)
$16.10+$0.56 (+3.64%)
LYEL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.53 | ||
Change | +$0.18 (+1.17%) | ||
Open | $15.54 | ||
High | $16.16 | ||
Low | $15.20 | ||
Previous Close | $15.35 | ||
Volume | 104,914 | ||
30-Day Average Volume | 170,723 | ||
1-Week Change | 11.33% | ||
1-Month Change | 18.46% | ||
1-Year Change | 44.33% | ||
3-Year Change | -64.86% | ||
5-Year Change | -94.87% | ||
Fundamentals | |||
Shares Outstanding | 24.5M | ||
Total Assets | $311.2M | ||
Market Cap | $380.6M | ||
Enterprise Value | $307.6M | ||
Period: QTR TTM FY | |||
Revenue | $4,000.00 | ||
Net Income | -$44.8M | ||
Free Cash Flow | -$34.2M | ||
EBIT | -$44.8M | ||
EBITDA | -$42.5M | ||
Net Working Capital | $173.7M | ||
EPS | -$1.92 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 76,895 | ||
P/B | 2 | ||
P/E | -8 | ||
PEG | 0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 06/02/2025 | ||
Earnings & Revenue